Subcutaneous EEG System Feasible, Acceptable for Monitoring Seizures
By Elana Gotkine HealthDay Reporter

WEDNESDAY, Aug. 20, 2025 -- Novel subcutaneous electroencephalography (sqEEG) systems, consisting of a small electrode placed beneath the skin, are feasible and acceptable for monitoring seizures in the long term, according to a study published online July 19 in Epilepsia.
Pedro F. Viana, M.D., Ph.D., from King's College London, and colleagues conducted a 15-month prospective, observational study including 10 adults with treatment-resistant epilepsy. Patients were asked to record sqEEG, to use an electronic seizure diary, and to complete acceptability and usability questionnaires after device implantation.
Ten patients recorded a median of 18.8 hours/day over a median duration of 438 days, totaling 71,984 hours of real-world sqEEG data. The researchers found that throughout the study, adherence and acceptability remained high. Across the patients, 754 sqEEG seizures were recorded, although 52 percent were not reported in the patient diary. Most (68 percent) of the 140 diary reports not associated with an identifiable seizure were reported as seizures with preserved awareness. There was high variability in the sqEEG-to-diary F1 agreement score, ranging from 0.06 to 0.97. There were patient-specific patterns of circadian seizure occurrence and seizure clustering observed, including several relevant discrepancies between the sqEEG and diary.
"The ability to monitor seizures in the real world, accurately collecting data on the type and timing that they occur, will be an invaluable tool for clinicians moving forward and should hopefully have a big impact on how we approach the treatment of this life-threatening condition," Viana said in a statement.
Several authors disclosed ties to the medical device industry.
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
Source: HealthDay
Posted : 2025-08-21 06:00
Read more

- The Many Faces of Parkinson’s: Symptoms, Treatment, and How To Manage It
- FDA Warns About Safety Issues With Boston Scientific Heart Devices
- Polygenic Scores for BMI Can Improve Prediction of Future Obesity
- Verbal Abuse As Damaging As Physical Abuse To Children's Mental Health
- Novel Treatments Recommended for Management of Atopic Dermatitis in Adults
- Patients With Leukemia Have Higher Infection Risk During Immunoglobulin Replacement Therapy
Disclaimer
Every effort has been made to ensure that the information provided by Drugslib.com is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. Drugslib.com information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Drugslib.com does not warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise. Drugslib.com's drug information does not endorse drugs, diagnose patients or recommend therapy. Drugslib.com's drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.
The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. Drugslib.com does not assume any responsibility for any aspect of healthcare administered with the aid of information Drugslib.com provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Popular Keywords
- metformin obat apa
- alahan panjang
- glimepiride obat apa
- takikardia adalah
- erau ernie
- pradiabetes
- besar88
- atrofi adalah
- kutu anjing
- trakeostomi
- mayzent pi
- enbrel auto injector not working
- enbrel interactions
- lenvima life expectancy
- leqvio pi
- what is lenvima
- lenvima pi
- empagliflozin-linagliptin
- encourage foundation for enbrel
- qulipta drug interactions